Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia

Nutrition Research

Volumn 30, Issue 12, 2010, Pages 858-864

  Chao, Chia Lun ^a,b   Weng, Ching Sung ^c   Chang, Nen Chung ^d   Lin, Jih Shyong ^a   Kao, Shung Te ^e   Ho, Feng Ming ^a,e  

^a TAOYUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

COX 2; Inflammation; INOS; Macrophage; Microglia; Naringenin

Indexed keywords

ASCORBIC ACID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NARINGENIN; NITRITE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASCORBIC ACID; CELL SURVIVAL; CITRUS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PLANT EXTRACTS;

EID: 78649938112     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.10.011     Document Type: Article

References (38)

1. Chamorro A., Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006, 37:291-293.
2. Ridker P.M. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 2007, 65:S253-S259.
3. Akasaka Y., Morimoto N., Ishikawa Y., Fujita K., Ito K., Kimura-Matsumoto M., Ishiguro S., Morita H., Kobayashi Y., Ishii T. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol 2006, 19:588-598.
4. Denker S.P., Ji S., Dingman A., Lee S.Y., Derugin N., Wendland M.F., Vexler Z.S. Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem 2007, 100:893-904.
5. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol 2007, 184:53-68.
6. Saito T., Rodger I.W., Shennib H., Hu F., Tayara L., Giaid A. Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor. Can J Physiol Pharmacol 2003, 81:114-119.
7. Son H.Y., Han H.S., Jung H.W., Park Y.K. Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia. J Pharmacol Sci 2009, 109:368-379.
8. Buttros J.B., Bergamaschi C.T., Ribeiro D.A., Fracalossi A.C., Campos R.R. Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Pharmacology 2009, 84:29-37.
9. Ribeiro D.A., Buttros J.B., Oshima C.T., Bergamaschi C.T., Campos R.R. Ascorbic acid prevents acute myocardial infarction induced by isoproterenol in rats: role of inducible nitric oxide synthase production. J Mol Histol 2009, 40:99-105.
10. García-Lafuente A., Guillamón E., Villares A., Rostagno M.A., Martínez J.A. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009, 58:537-552.
11. Hirvonen T., Pietinen P., Virtanen M., Ovaskainen M.L., Häkkinen S., Albanes D., Virtamo J. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 2001, 12:62-67.
12. Geleijnse J.M., Launer L.J., Van der Kuip D.A., Hofman A., Witteman J.C. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002, 75:880-886.
13. Keli S.O., Hertog M.G., Feskens E.J., Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996, 156:637-642.
14. Knekt P., Kumpulainen J., Järvinen R., Rissanen H., Heliövaara M., Reunanen A., Hakulinen T., Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002, 76:560-568.
15. Ulrich-Merzenich G., Zeitler H., Vetter H., Kraft K. Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling. Phytomedicine 2009, 16:2-16.
16. Kim M.S., Park S.B., Suk K., Kim I.K., Kim S.Y., Kim J.A., Lee S.H., Kim S.H. Gallotannin isolated from Euphorbia species, 1,2,6-tri-O-galloyl-beta-d-allose, decreases nitric oxide production through inhibition of nuclear factor-kappa B and downstream inducible nitric oxide synthase expression in macrophages. Biol Pharm Bull 2009, 32:1053-1056.
17. Tsai S.H., Lin-Shiau S.Y., Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 1999, 126:673-680.
18. Raso G.M., Meli R., Di Carlo G., Pacilio M., Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001, 68:921-931.
19. Hämäläinen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappa B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappa B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007, 2007:45673.
20. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J., Spencer J.P. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 2009, 484:100-109.
21. White C.A., McCombe P.A., Pender M.P. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95). Int Immunol 1998, 10:935-941.
22. Park J.S., Woo M.S., Kim D.H., Hyun J.W., Kim W.K., Lee J.C., Kim H.S. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells. J Pharmacol Exp Ther 2007, 320:1237-1245.
23. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004, 36:592-604.
24. Vauzour D., Vafeiadou K., Rodriguez-Mateos A., Rendeiro C., Spencer J.P. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 2008, 3:115-126.
25. Shibakawa Y.S., Sasaki Y., Goshima Y., Echigo N., Kamiya Y., Kurahashi K., Yamada Y., Andoh T. Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth 2005, 95:803-810.
26. Sesso H.D., Buring J.E., Christen W.G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J.E., Glynn R.J., Gaziano J.M. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
27. Willcox B.J., Curb J.D., Rodriguez B.L. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol 2008, 101:75D-86D.
28. Rizzo M.R., Abbatecola A.M., Barbieri M., Vietri M.T., Cioffi M., Grella R., Molinari A., Forsey R., Powell J., Paolisso G. Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action. J Am Coll Nutr 2008, 27:505-511.
29. Tousoulis D., Antoniades C., Tentolouris C., Tsioufis C., Toutouza M., Toutouzas P., Stefanadis C. Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 2003, 170:261-267.
30. Wynne H., Khan T., Avery P., Wood P., Ward A., Kamali F. Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin. Thromb Res 2006, 118:501-504.
31. Castilla P., Echarri R., Dávalos A., Cerrato F., Ortega H., Teruel J.L., Lucas M.F., Gómez-Coronado D., Ortuño J., Lasunción M.A. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 2006, 84:252-262.
32. Chao C.L., Hou Y.C., Chao P.D., Weng C.S., Ho F.M. The antioxidant effects of quercetin metabolites on the prevention of high glucose-induced apoptosis of human umbilical vein endothelial cells. Br J Nutr 2009, 101:1165-1170.
33. Rössig L., Hoffmann J., Hugel B., Mallat Z., Haase A., Freyssinet J.M., Tedgui A., Aicher A., Zeiher A.M., Dimmeler S. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001, 104:2182-2187.
34. Kanaze F.I., Bounartzi M.I., Georgarakis M., Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007, 61:472-477.
35. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
36. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
37. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81:243S-255S.
38. Fang S.H., Hou Y.C., Chang W.C., Hsiu S.L., Chao P.D., Chiang B.L. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci 2003, 74:743-756.